Category Archives: Neglected Diseases

The Zika loopholes

The FDA has a smart-sounding program to drive research for neglected diseases—with two big flaws. Politico; March 25, 2016. By Willo Brock, Rachel Cohen, Jason Cone and Lindsay McKenna. Last week, the Senate voted to add Zika to the list of neglected … Continue reading

Posted in Innovation, Neglected Diseases, Priority Review | Leave a comment

G-Finder Report: Ebola Distracted R&D Funding For Neglected Diseases; Public Funding At Low

IP Watch; December 8, 2015. A newly issued report provides the “first ever” picture of global investment in Ebola research and development. The report found that investment in Ebola might have come at the expense of other funding to develop drugs, … Continue reading

Posted in Ebola, Innovation, Neglected Diseases, Public research | Leave a comment

Shkreli’s KaloBios buys an old drug with eyes on a lucrative FDA voucher

KaloBios, a once-doomed company brought back from the brink by biotech entrepreneur Martin Shkreli, bought the rights to an old antiparasitic drug with hopes of winning FDA approval and securing one of the agency’s valuable priority review vouchers.

Posted in Neglected Diseases, USFDA | Leave a comment

Health Groups Ask Senate for Changes to FDA Priority Review Voucher Program for Neglected Diseases

MSF, November 19, 2015. On November 17, 2015, Doctors Without Borders/Médecins Sans Frontières (MSF), the American Thoracic Society, the Drugs for Neglected Diseases initiative (DNDi), the Global Alliance for TB Drug Development, the IDSA Center for Global Health Policy, the Sabin … Continue reading

Posted in Innovation, Neglected Diseases | Leave a comment

Nobel prize winners point the way in battle against diseases of poverty

The Guardian; October 30, 2015. What does it take to bring the fruits of scientific innovation to vulnerable patients in the world’s poorest communities? The discoveries recognised by the 2015 Nobel prize for medicine are perfect examples of the journey from test … Continue reading

Posted in Innovation, Malaria, Neglected Diseases | Leave a comment

Effective snakebite treatment due to expire next year

SciDevNet; November 2, 2015. One of the most effective treatments for snakebite could run out in June 2016, putting the lives of tens of thousands of people in Sub-Saharan Africa at risk, Médecins Sans Frontières (MSF) has warned. The French … Continue reading

Posted in Neglected Diseases | Leave a comment